TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 2 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,000 | -61.1% | 13,149 | +0.8% | 0.00% | – |
| Q1 2019 | $18,000 | -68.4% | 13,048 | -17.2% | 0.00% | – |
| Q2 2018 | $57,000 | -18.6% | 15,752 | -31.6% | 0.00% | – |
| Q1 2018 | $70,000 | -57.3% | 23,013 | -11.8% | 0.00% | – |
| Q4 2017 | $164,000 | -34.7% | 26,094 | -28.8% | 0.00% | – |
| Q3 2017 | $251,000 | +146.1% | 36,664 | +231.7% | 0.00% | – |
| Q1 2017 | $102,000 | +9.7% | 11,054 | -52.6% | 0.00% | – |
| Q4 2016 | $93,000 | -46.2% | 23,327 | -48.3% | 0.00% | – |
| Q3 2016 | $173,000 | -16.8% | 45,159 | -6.2% | 0.00% | – |
| Q2 2016 | $208,000 | -23.2% | 48,126 | -17.7% | 0.00% | – |
| Q1 2016 | $271,000 | -63.4% | 58,482 | -20.7% | 0.00% | -100.0% |
| Q4 2015 | $741,000 | +120.5% | 73,789 | +64.1% | 0.00% | – |
| Q3 2015 | $336,000 | -88.0% | 44,967 | -24.1% | 0.00% | -100.0% |
| Q2 2015 | $2,809,000 | +146.6% | 59,215 | +90.4% | 0.00% | +200.0% |
| Q1 2015 | $1,139,000 | +58.6% | 31,103 | +72.0% | 0.00% | 0.0% |
| Q4 2014 | $718,000 | +136.2% | 18,079 | -35.3% | 0.00% | – |
| Q1 2014 | $304,000 | +35.7% | 27,932 | +68.5% | 0.00% | – |
| Q4 2013 | $224,000 | -54.1% | 16,575 | -76.1% | 0.00% | – |
| Q2 2013 | $488,000 | – | 69,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
| BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
| Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
| Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
| Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
| Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
| Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |